RxDoctor Payments Data

Kristi Lickteig

Psychiatric/Mental Health · Garnett, KSNPI 1437770559

Payments from drug & device makers

$2,357in general payments, 2019–2025

Across 144 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$576
  • Teva Pharmaceuticals USA, Inc.$342
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$242
  • Axsome Therapeutics, Inc.$238
  • Lundbeck LLC$226
  • AbbVie$219
  • plus $514 from 6 others

What the payments were for

  • Food & beverage$2,357100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,357 in reported general payments places this provider in the 75th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$5,421
Medicare patients
14
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$43,730
RexultiBrexpiprazole20$28,962
VraylarCariprazine Hcl12$20,702
Olanzapine83$1,775
Fluphenazine Hcl34$1,711
Desvenlafaxine Succinate ErDesvenlafaxine Succinate30$1,701
Zolpidem Tartrate58$1,608
Buspirone Hcl75$1,469
Divalproex Sodium ErDivalproex Sodium35$1,125
Ziprasidone Hcl36$891
Trazodone Hcl53$813
Aripiprazole33$604
Amitriptyline Hcl40$555
Quetiapine Fumarate17$362
Venlafaxine Hcl ErVenlafaxine Hcl32$352

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$163$43,73015 claims
Otsuka America Pharmaceutical, Inc.Rexulti$576$28,96220 claims
AbbVieVraylar$219$20,70212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Garnett

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →